These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2506511)

  • 21. [In vitro activity of 4 fluoroquinolones against Klebsiella pneumoniae. Distribution according to phenotype resistance to aminoglycosides or beta-lactams].
    Miguères ML; Ronco E; Guenounou M
    Pathol Biol (Paris); 1990 May; 38(5):385-9. PubMed ID: 2195447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In-vitro activity of fleroxacin compared with three other quinolones.
    Bremner DA; Dickie AS; Singh KP
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():19-23. PubMed ID: 3144536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [In vitro antibacterial activity of rokitamycin, a new macrolide antibiotic. Results of a multicenter study].
    Soussy CJ; Le Van Thoi J; Meyran M; Joly B; Derlot E; Morel C
    Pathol Biol (Paris); 1990 May; 38(5):407-12. PubMed ID: 2195450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activity of pefloxacin compared to that of quinolones and other antimicrobial agents.
    Neu HC; Chin NX; Labthavikul P; Saha G
    Chemioterapia; 1984 Aug; 3(4):235-41. PubMed ID: 6241847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Susceptibility to quinolones of Salmonella isolated from men and animals].
    Avril JL; Couete I; Travert MF; Autuly F; Plessis P
    Pathol Biol (Paris); 1995 Apr; 43(4):270-3. PubMed ID: 7567113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [In vitro antibacterial activity of piperacillin/quinolone combinations].
    Soussy CJ; Leclercq R; Duval J
    Pathol Biol (Paris); 1988 May; 36(5):357-60. PubMed ID: 3136421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Multicenter study of the in vitro effect of imipenem (N-formimidoyl-thienamycin) on hospital bacteria].
    Soussy CJ; Otterbein G; Le Van Thoi J; Thabaut A; Meyran M; Courtieu AL; Reynaud A; Dabernat H; Lareng MB; Chanal M
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):487-92. PubMed ID: 3911142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series.
    Slinger R; Desjardins M; McCarthy AE; Ramotar K; Jessamine P; Guibord C; Toye B
    BMC Infect Dis; 2004 Sep; 4():36. PubMed ID: 15380025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mutations of gyrA in ciprofloxacin resistant Escherichia coli strains].
    Eraç B; Gill A; Amyes SG; Gülay Z
    Mikrobiyol Bul; 2003; 37(2-3):125-30. PubMed ID: 14593893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [In vitro antibacterial effect of a new oral cephalosporin, cefixime. Results of a multicenter study].
    Soussy CJ; Kitzis MD; Thabaut A; Chanal M; Bure A; Vergnaud M; Reynaud AE; Coulet M; Dabernat H; Muller-Serieys C
    Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):528-33. PubMed ID: 2508039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Compared antibacterial activity of a new fluoroquinolone, sparfloxacin (AT 4140, RP 64206) and four other fluoroquinolones against 332 strains of enteropathogen bacteria].
    Le Noc P; Croizé J; Le Noc D
    Pathol Biol (Paris); 1993 Apr; 41(4):294-301. PubMed ID: 8233625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In-vitro activity of fleroxacin against urinary tract and genital tract pathogens.
    Dubois J; Fontaine V
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():31-4. PubMed ID: 3144546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of MICs for staphylococci using the API ATB quinolone and API ATB macrolide systems.
    Rohner P; Peyret M; Auckenthaler R
    Pathol Biol (Paris); 1993 Apr; 41(4):323-8. PubMed ID: 8233630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Multicenter study of ofloxacin activity on bacteria isolated from a hospital environment].
    Soussy CJ; Le Van Thoi J; Duval J; Morel C; Malbruny B; Acar JF; Kitzis MD; Mounier M; Denis F; Courvalin P
    Pathol Biol (Paris); 1986 May; 34(5):390-8. PubMed ID: 3534711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [In vitro antibacterial activity of a new macrolide, miokamycin. Results of a multicenter study].
    Soussy CJ; Thabaut A; Bismuth R; Morel C; Berthelot G; Chanal M; Derlot E
    Pathol Biol (Paris); 1989 May; 37(5):358-63. PubMed ID: 2674868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [In vitro determination of the sensitivity of mycobacteria to fluoroquinolones].
    Dailloux M; Petitpain N; Henry C; Weber M
    Pathol Biol (Paris); 1989 May; 37(5):346-9. PubMed ID: 2780092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Growing incidence of nalidixic acid resistance and sensitivity to quinolones in Salmonella typhimurium strains isolated from man or animal].
    Heurtin-Le Corre C; Donnio PY; Bonnier M; Travert MF; Lacourt A; Avril JL
    Pathol Biol (Paris); 1998 Oct; 46(8):587-90. PubMed ID: 9871929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A multicenter study on the comparative in vitro activity of fleroxacin and three other quinolones: an interim report from 27 centers.
    Beskid G; Prosser BL
    Am J Med; 1993 Mar; 94(3A):2S-8S. PubMed ID: 8383919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Quinolone resistance in Salmonella enterica].
    Seral C; López L; Castillo FJ; Clavel A; Rubio MC
    Rev Esp Quimioter; 1998 Mar; 11(1):43-6. PubMed ID: 9795288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In-vitro activity of fleroxacin.
    Georgopoulos A; Breyer S; Georgopoulos M; Mailer H; Graninger W
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():25-9. PubMed ID: 3144544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.